mpnmds Flashcards

1
Q

what is the defeinition of a myeloproliferative neoplasms

A

group of clonol myeloid neoplasma characterized by proliferation of one or more cell type in peripheral blood with minimal dysplasia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are some common feature of myeloproliferative neoplasms

A

basophilia and splenomegaly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the median age of CML diagnosis

A

46-53 years of age

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what percent of people with CML are asymptomatic

A

40.00%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are the pathological features of the chronic phase of CML

A

peripheral blood left shifted more granulocytosis in all states netrophilia with myelocyte bulge.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what do you see in the chronic phase of CML in the Bone marrow aspirate or biopsy

A

markedly hyper-cellular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is the difference between the major minor and kilodaltion breakpoints for BCR ABL of CML

A

major p210 vast majority, minor p190, kilodaltion p230 cml with thrombosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is CML in the accelerated phase

A

peripheral blood or BM blasts in less than 20% PB basophilia less than 20%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is CML in the blast phase

A

PB or BM greater than 20%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

tell me about CML in general

A

tyrosine kinase overactivity due to a translocation of chormosones 9 and 22

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is the treatment of CML

A

imatanib or stem cell tranplantation for younger patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is the prognosis of CML

A

4-6 years in the chornic phase then in the terminal blast phase with imatinib prolonged survival.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what do you see in leukemoid reactions

A

Nml resonse to infection segs and bands no basophilia or splenomegaly LAP score elevated normal megas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what do you see in the CML

A

clonol MPN myelocyte bulge basophilia and splenomegaly LAP score decreased dwarf megas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is polycythemia vera

A

increased RBC mass RBC HGB and HCT, medain age about 60

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are the clinical features of polycythemia VERA PV

A

hyperviscosity related symptoms pruritus after warm shower.

17
Q

what is the diagnosis criteria for PV

A

2 major and 1 minor or I major and 2 minor, major criteria HGB >18.5 men 16.5 women JAK2 mutation, minor hypercellular marrow with panmyelosis low serum epo endogenous erythroid colony formation in vitro.

18
Q

what are the pathological features of polycythemic phase

A

peripheral blood erythrocytosis and in the bone marrow hyperceulluar with panmyelosis erythroid predominance variable enlarged megakaryocytes and clustered.

19
Q

what are the pathological features of the spent phase of PV

A

leukoerytrhoblastosis left shifrted neutrophils and tear drob shaped RBC bone marrow often a dry tap increasing fibrosis

20
Q

what is the pathophysiology of PV

A

JAK2 tyrosine kinase point mutation accounts for more than 95%

21
Q

what is the treatment of PV

A

blood letting myelosuppresive drugs 15 year survival of 65% worse with history of thrombosis

22
Q

what are some differnentail diagnosis of r PV

A

secondary polycythemina due to smoking high altitude ECT>

23
Q

how can you differnatial between secondary polycythemia and PV

A

clonol MPN decreased EPO splenomegaly penlarged megas in PV

24
Q

what is Essential thrombocytosis

A

increased platelat production more than 450k

25
what are the clinical feature of essential thrombocytosis
mary are asymptomatic can lead to thrombosis splenomegaly hemmorhage
26
how can you diagnose ET
need all four more than 450K plateltes bone marrow megakaryocytic hyperplasia, JAK2 V617F mutation and not meeting criteria for other MPN MDS and myeloid neoplasm